The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
India's Wockhardt partners with Chinese company to develop novel antibiotic Nafithromycin
India's Wockhardt has partnered with China's Jiangxi Jemincare Group Company to develop and commercialize novel broad-spectrum antibiotic Nafithromycin, the Indian company said in its filing with the Bombay Stock Exchange on Thursday.
Jiangxi Jemincare Group Co., Ltd. was founded in 1999. Its pharmaceutical history can be traced back to the 1950s with 12,000 employees. It has many industrial platforms and R&D institutes in Jiangxi, Beijing, Shanghai, Jiangsu and Zhejiang.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to firstname.lastname@example.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.